Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind

Michael Migden, John Lear, Nicholas Squittieri, Li Liu, Alexander Guminski, Reinhard Dummer
2020 SKIN The Journal of Cutaneous Medicine  
not available.
doi:10.25251/skin.4.supp.67 fatcat:ltjpq34htzbmva2sk6hhzxr6qm